Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00182507
Status:
COMPLETED
Last Update Posted:
2006-09-11
First Post:
2005-09-14
Brief Title:
Olanzapine in the Treatment of Hair Pulling Trichotillomania
Sponsor:
Hamilton Health Sciences Corporation
Organization:
McMaster University
Study Overview
Official Title:
A 12-Week Double-Blind Trial of Olanzapine and Placebo in the Treatment of Trichotillomania
Status:
COMPLETED
Status Verified Date:
2006-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Trichotillomania TTM or hair-pulling has been considered as part of the obsessive compulsive disorder OCD spectrum although treatment with OCD medications has largely been unsuccessful TicsTourrettes Syndrome TS is a disorder which appears to be related to TTM but is treated with a different class of medications than used in OCD namely antipsychotics such as olanzapine This is a study of the safety and efficacy of olanzapine in the treatment of hair pulling
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None